Nana Ama Quartey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |
Michael Joseph Greco, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 |
Dr. Eugene C.h. Ko, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 446 N Reading Rd, Suite 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6010 |
Traci M Kohl, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd, Suite 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6010 |
Agnieszka Ewelina Mochon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd Ste 302, Ephrata, PA 17522 Phone: 717-738-0167 Fax: 717-291-9634 |
Bashirat Lola Giwa, M.D., MSPH Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd Ste 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-738-6010 |
Eliyahu E Fuchs, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 175 Martin Avenue, Suite 350, Ephrata, PA 17522 Phone: 717-738-5648 Fax: 717-327-4014 |
Dr. John T Joseph, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd, Ephrata, PA 17522 Phone: 717-738-4334 Fax: 717-438-3289 |
News Archive
A review of global fertility care, completed for World Infertility Month (June), has revealed that 94% of the 90 million patients around the world with fertility problems never receive any kind of care for their condition.
In 2001, Mount Sinai researchers published a study in Science that showed that a gene, known as KLF6, fails to function properly in at least 50 to 60 percent of all prostate cancers. This was the first single gene shown to be responsible for the majority of cases of this disease, which affects approximately 200,000 men each year.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight® Dx Pulmotax™ assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC," included 368 samples from carcinoma patients.
Psychologists have been exploring this question, and more specifically a possible link between tenacity and both physical and mental health.
In 2005, Americans spent 53 percent per capita more than the next highest country, Switzerland, and 140 percent above the median industrialized country, according to new research from the Johns Hopkins Bloomberg School of Public Health.
› Verified 8 days ago